0001213900-25-126622.txt : 20251230
0001213900-25-126622.hdr.sgml : 20251230
20251230161502
ACCESSION NUMBER: 0001213900-25-126622
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20251230
DATE AS OF CHANGE: 20251230
EFFECTIVENESS DATE: 20251230
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurotrigger Ltd.
CENTRAL INDEX KEY: 0001987476
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-568468
FILM NUMBER: 251614438
BUSINESS ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 4 SHEZAF STREET
CITY: RA'ANANA
PROVINCE COUNTRY: L3
BUSINESS PHONE: 972522963130
MAIL ADDRESS:
ADDRESS IS A NON US LOCATION: YES
STREET 1: 4 SHEZAF STREET
CITY: RA'ANANA
PROVINCE COUNTRY: L3
D
1
primary_doc.xml
X0708
D
LIVE
0001987476
Neurotrigger Ltd.
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
+972522963130
ISRAEL
None
None
Corporation
true
Nikolai
Kunicher
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Executive Officer
Chief Executive Officer
Michal
Marks
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Executive Officer
Director
Chief Operating Officer and Director
Prof. Eyal
Gur
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Executive Officer
Medical Director
Dr. Assaf
Deutsch
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Executive Officer
Director
R&D Director and Director
Shachar
Paz
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Director
Dr. Hagit
Deutsch
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Director
Shalom
Auerbach
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Director
James
Mazzo
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Director
Dr. Barak
Azmon
3 HATAMAR STREET
EVEN YEHUDA
L3
ISRAEL
4050003
Director
Other Health Care
Decline to Disclose
- 06b
false
2025-10-05
false
true
false
0
None
None
None
None
None
None
XX
Unknown
00000
true
724980
724980
0
On June 4, 2025, the company entered into a securities purchase agreement, as amended on October 5, 2025, pursuant to which the company agreed to issue 12,083 ordinary shares, par value NIS 0.01 per share, for the price of $60.00 per share.
true
0
1
0
0
0
false
Neurotrigger Ltd.
/s/ Nikolai Kunicher
Nikolai Kunicher
Chief Executive Officer
2025-12-30